biostrategyanalytics.com
Is the Celgene / Amgen deal for Otezla fair?
Celgene recently disposed Otezla indicated for the treatment of psoriasis and psoriatic arthritis to Amgen in $13.4bn deal. Therefore, the question that is raised at this point is whether the deal …